Prof Gordon McVie provides highlights from ecancer for August 2016:
Video
The future of cancer prevention
Update on CaPP3 in high risk populations
Deciphering RAS/MAPK signalling in cancer
Journal
Negative trials in ovarian cancer: is there such a thing as too much optimism?
Complications from carcinoid syndrome: review of the current evidence
Role of nanotechnology and gene delivery systems in TRAIL based therapies
Education